More Drugmakers Join TrumpRx
via HealthDayWEDNESDAY, April 8, 2026 — Drug companies Abbvie and Genentech will start selling medications at lower prices through the White House’s "TrumpRx" website.
They are the 10th and 11th companies to join the program.
Abbvie will offer its arthritis drug Humira at a steep discount.
The medication, which is also used to treat Crohn’s disease and ulcerative colitis, can cost more than $6,900 for folks without insurance.
Through the program, the price will drop to about $950, a roughly 86% discount, a White House official told CBS News.
Genentech will sell its flu treatment Xofluza for about $50, down from $168.
The discounted prices are available only for cash-paying patients — those without insurance or whose insurer doesn’t cover a medication.
Patients who have insurance usually pay less than the full list price, CBS News said.
The program is based on "most-favored-nation" pricing agreements, which aim to match U.S. drug prices to the lower prices seen in other countries.
The White House says it is working to expand the program so people with government insurance can use their copays on the TrumpRx site.
Congress has not approved those changes just yet, CBS News noted.
Another company, Amgen, is also expanding its TrumpRx offerings to include the arthritis drug Enbrel and psoriasis drug Otezla.
The site now lists more than 61 discounted medications, up from about 40 when it launched in February, CBS News reported.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-04-09 02:11
Read more
- Two States Sue Cord Blood Company Over Misleading Claims
- Levels of Burnout Elevated for Sickle Cell Disease-Focused Physicians
- AHA: Sedentary Behavior, Light-Intensity Exercise Predictive of Hypertensive Disorders of Pregnancy
- Cognitive, Linguistic Deficits in Kindergarten Linked to Dyslexia Risk
- Risk for Dementia May Be Increased by Severe Infections
- Online Tool Enables Communication of Genetic Testing Results With Family Members
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions